Clinical trial
Dolastatin 10 in Treating Patients With Recurrent or Metastatic Soft Tissue…
NCT00003778 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00003778 |
|---|---|
| Title | Dolastatin 10 in Treating Patients With Recurrent or Metastatic Soft Tissue Sarcoma |
| Official title | Phase II Trial of Dolastatin-10 in Patients With Previously Untreated Recurrent/Metastatic Sarcoma |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Ovarian Cancer, Sarcoma |
| Intervention type | Drug |
| Interventions | dolastatin 10 |
| Enrollment | 37 |
| Start date | Apr 1, 1999 |
| Primary completion | Jul 1, 2000 |
| First posted | Aug 27, 2004 |
| Last update posted | Feb 8, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: